Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/1993
10/20/1993EP0566347A2 Use of yeast cell debris products
10/20/1993EP0566142A1 Inclusion complexes of optically active and racemic 1,4-dihydro pyridines with cyclodextrin derivates
10/20/1993EP0566135A1 Transmucosal composition comprising a peptide and a cytidine derivative
10/20/1993EP0565706A1 Water-soluble delivery systems for hydrophobic liquids.
10/20/1993EP0565658A1 Verbenone, having antielastase activity, against pulmonary emphysema
10/20/1993EP0565620A1 Mitotoxin for treatment of vascular injury.
10/20/1993EP0565618A1 Stabilization of proteins by cationic biopolymers
10/20/1993EP0553121A4 Aqueous emulsion and aerosol delivery system using same
10/20/1993EP0480982B1 Vaccines and vectors with liquid active principles containing an oil which can be metabolised
10/20/1993EP0480981B1 Injectable multi-phase emulsions
10/20/1993EP0458930B1 STABILIZATION OF GLYCOSYLIZED t-PA
10/20/1993EP0436726B1 Method of photostabilizing eyewash
10/20/1993EP0398925B1 Growth inhibiting agent and the use thereof
10/19/1993US5254671 Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor
10/19/1993US5254636 Rapid hydrolysis of crosslinked maleic anhydride/lower alkyl vinyl ether copolymers
10/19/1993US5254545 Stabilized with lactose, citric acid, arginine or sodium chloride; antibiotics
10/19/1993US5254541 (Quinolin-2-ylmethoxy)indole/cyclodextrin complex
10/19/1993US5254342 Compositions and methods for enhanced transepithelial and transendothelial transport or active agents
10/19/1993US5254339 Solubilizing antigen; complexing with glycosides containing hydrophobic and hydrophilic domains; isolation; purification
10/19/1993US5254338 N-vinylacetamide polymer
10/19/1993US5254330 Aerosol carriers
10/19/1993CA1323306C Pharmacological agent-lipid solution preparation
10/19/1993CA1323305C Delivery systems for pharmacological agents
10/19/1993CA1323303C Advanced anticancer therapy and cytotoxic medicaments for its implementation
10/18/1993CA2094217A1 Transmucosal therapeutic composition
10/17/1993CA2094023A1 Yeast debris products
10/14/1993WO1993020439A1 Compositions and methods for regulating cellular signal transducing systems
10/14/1993WO1993020229A1 ANTIBODIES TO ALPHAvBETA3 INTEGRIN
10/14/1993WO1993020207A1 Use of restriction endonucleases against viruses, including hiv
10/14/1993WO1993020168A1 A method of controlling the oxidation of chemicals during storage using noble gases
10/14/1993WO1993020126A1 Biodegradable polycarbonates and their use as drug carriers
10/14/1993WO1993020102A1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis
10/14/1993WO1993020076A1 Catalytic antibodies against cocaine and methods of using and producing same
10/14/1993WO1993020067A1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof
10/14/1993WO1993019805A1 Fibrin sealant delivery method
10/14/1993WO1993019788A1 Methods and compositions for magnetic resonance imaging
10/14/1993WO1993019780A1 Hepatitis vaccines containing 3-o-deacylated monophoshoryl lipid a
10/14/1993WO1993019777A1 Fusion proteins comprising tumor necrosis factor receptor
10/14/1993WO1993019776A1 Protein formulation comprising growth hormone
10/14/1993WO1993019773A1 Lyophilized somatotropin formulations
10/14/1993WO1993019771A1 Pernasal preparation containing granulocyte colony-stimulating factor
10/14/1993WO1993019768A1 Self-assembling polynucleotide delivery system
10/14/1993WO1993019763A1 Rapamycin formulation for iv injection
10/14/1993WO1993019753A1 Parenteral solutions containing 3-dialkylaminoethoxybenzoyl-benzofurans
10/14/1993WO1993019746A1 Topical administration of toremifene and its metabolites
10/14/1993WO1993019740A1 Methods of manufacturing high dosage glutathione, the tablets and capsules produced thereby
10/14/1993WO1993019739A1 Viscous suspensions of controlled-release drug particles
10/14/1993WO1993019738A1 Method of treatment of infected tissues
10/14/1993WO1993019737A1 A pharmaceutical composition containing a defined lipid system
10/14/1993WO1993019736A1 A pharmaceutical carrier system containing defined lipids
10/14/1993WO1993019733A1 Moisturizer
10/14/1993WO1993019668A1 Method and kit for imaging and treating organs and tissues
10/14/1993CA2133737A1 Lyophilized somatotropin formulations
10/14/1993CA2133109A1 Moisturizer
10/14/1993CA2132744A1 Methods and compositions for magnetic resonance imaging
10/14/1993CA2132624A1 Compositions and methods for regulating cellular signal transducing systems
10/14/1993CA2132516A1 Peptide t and related peptides in the treatment of inflammation, including multiple sclerosis
10/14/1993CA2132341A1 Benzodiazepine derivatives and protein and polypeptide conjugates thereof
10/14/1993CA2128621A1 Biodegradable polycarbonates and their use as drug carriers
10/14/1993CA2117495A1 Fibrin sealant delivery method
10/14/1993CA2102779A1 A method of controlling the oxidation of chemicals during storage using noble gases
10/13/1993EP0565301A1 Prolonged-release liquid type of pharmaceutical preparation
10/13/1993EP0565241A1 Oligosaccharides
10/13/1993EP0565236A2 Colour-coded inactivated vaccines for poultry
10/13/1993EP0564537A1 Stable suspension formulations for controlled delivery of pharmaceutical compounds
10/13/1993EP0564531A1 Enrichment method for variant proteins with altered binding properties
10/13/1993EP0560937A4 Pharmaceutical compositions
10/13/1993EP0527942A4 Colonic drug delivery system
10/12/1993US5252713 Polymeric carriers for non-covalent drug conjugation
10/12/1993US5252711 Monoclonal antibodies useful in deodorizing skin and antibody fragments thereof
10/12/1993US5252673 Reaction product of divinyl ether-maleic anhydride copolymer, an aminoacid and mitomycin C; antitumor agents, anticarcino-genic
10/12/1993US5252588 Percutaneously absorbable crosslinked polyvinylpyrrolidone eperisone or tolperisone preparation
10/12/1993US5252561 Preparation for the controlled release of active substances which are suitable as a therapeutics or for improving growth and feed utilization in ruminants
10/12/1993US5252557 With sodium hyaluronate
10/12/1993US5252467 Method of making antibodies to antigenic epitopes of IGE present on B cells but not basophil cell surface or secreted, soluble IGE
10/12/1993US5252344 Hardening agent for affected tissues of the digestive system
10/12/1993US5252339 Pharmaceutical compositions containing orally absorbable glycosamimoglycans
10/12/1993US5252335 Transdermal administration of lisuride
10/12/1993US5252327 Solutions containing antigen and zinc hydroxide or iron hydroxide as an adjuvant and processes for preparing such solutions
10/12/1993US5252320 PVP-HI-I2 complexes having a partition coefficient above 300, and process for making same
10/12/1993US5252318 Reversible gelation compositions and methods of use
10/12/1993US5252246 Detergents for cleaning sensitive tissues such as eyes
10/12/1993CA1322957C Cyclic amp derivative ointments
10/07/1993DE4230588C1 Dexpanthenol-haltiges Pflaster zur transdermalen Applikation von Steroidhormonen und Verfahren zu seiner Herstellung Dexpanthenol-containing patch for transdermal administration of steroid hormones and process for its preparation
10/06/1993EP0564154A1 A pharmaceutical formulation in the form of aqueous suspension
10/06/1993EP0563813A1 Transdermal compositions
10/06/1993EP0563475A1 Cell binding agent conjugates of derivatives of CC-1065
10/06/1993EP0563294A1 Polyamine drug-resin complexes
10/06/1993EP0563227A1 Cosmetic or pharmaceutical composition in the form of a rigid gel, particularly for containing inclusions therein.
10/06/1993EP0563198A1 TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS
10/06/1993EP0563112A1 Enhanced bioavailability pharmaceutical composition containing probucol.
10/06/1993EP0563093A1 A composition used as a therapeutic agent against chronic viral hepatic diseases
10/06/1993EP0514435B1 Alcoholic aqueous gel-type phospholipid composition, its use and topical preparations containing it
10/05/1993US5250613 Solid surface coated with a hydrophilic outer layer with covalently bonded biopolymers, a method of making such a surface, and a conjugate therefor
10/05/1993US5250513 Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
10/05/1993US5250304 Treatment of iodine deficiency diseases
10/05/1993CA1322717C Combination of renal vasodilators and alpha 1-adrenergic or ganglionic blocking agents and methods for treating diseases
10/01/1993CA2092861A1 Transdermal compositions
09/1993
09/30/1993WO1993019177A1 FOUR NOVEL RECEPTORS OF THE TGF-β RECEPTOR FAMILY
09/30/1993WO1993019176A1 Leucine zippers
1 ... 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 ... 1712